Yale University, Comprehensive Cancer Center

New Haven, Connecticut 06520

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Colorectal Neoplasms Clinical Trial
A Phase II Multicenter, Randomized, Placebo Controlled, Double Blinded Clinical Study of KD018 as a Modulator of Irinotecan Chemotherapy in Patients With Metastatic Colorectal Cancer
Status: Enrolling, Phase II
Updated: 2/16/2016
Yale University, Comprehensive Cancer Center
mi
from
New Haven, CT
Click here to add this to my saved trials